Wird geladen...

Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy

Vascular endothelial growth factor (VEGF) has been shown to be an endothelial cell-specific mitogen and an angiogenic inducer in a variety of in vitro and in vivo models. Furthermore, it has been demonstrated to increase retinal vessel permeability by increasing the phosphorylation of tight junction...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Fernando Arevalo, J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Medical Hypothesis, Discovery & Innovation Ophthalmology 2013
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3939761/
https://ncbi.nlm.nih.gov/pubmed/24600636
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!